Pathologic Predictors of Microsatellite Instability in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Identification of microsatellite unstable (MSI-H) colorectal cancers (CRCs) is important not only for the identification of hereditary nonpolyposis colorectal cancer syndrome but also because MSI-H CRCs have a better prognosis and may respond differently to 5-fluorouracil-based chemotherapy. We present 2 nearly equivalent logistic regression models for clinical use that predict microsatellite instability based on the review of 1649 CRCs from patients of all ages collected in a population-based case control study in northern Israel. One hundred ninety-eight of these 1649 tumors demonstrated a high degree of microsatellite instability (12%). Multivariate analysis found that >2 tumor-infiltrating lymphocyte (TIL) cells per high-powered field, the lack of dirty necrosis, the presence of a Crohn-like reaction, right-sided location, any mucinous differentiation (mucinous or focally mucinous) and well or poor differentiation, and age less than 50 were all independent predictors of MSI-H. We developed 2 logistic regression models that differ only by the statistical approach used to analyze the number of TIL cells per high-powered field, where the slightly more accurate (and complex) model uses the log of the total number of TIL cells. The simpler clinical model uses a cut-off of 2>TIL cells per high-powered field. The accuracy of both models is high, with an 85.4% versus 85.0% probability of correctly classifying tumors as MSI-H. By employing the simpler model, pathologists can predict the likelihood of microsatellite instability by compiling the MSI probability score (Table 4 and Fig. 1) from simple histologic and clinical data available during sign-out. Our model shows that approximately 43% of CRCs have a MSI probability score of 1 or less and hence have little likelihood (<3%) of being MSI-H. Although this model is not perfect in predicting microsatellite instability, its use could improve the efficiency of expensive diagnostic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Qualitatively, we found that in many cases there was a histological phenotype known to be associated with either BRAF mutational status or MSI/ dMMR, such as mucinous histology and/or poor differentiation 30,31 .”
From Swarm learning for decentralized artificial intelligence in cancer histopathology (2022) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundBoland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183 · cited 2×
“A reasonable compromise may be to use clinical and histologic features as a guideline in deciding which cases should have additional testing, such as those recommended in the revised Bethesda Guidelines for HNPPC.38 These guidelines state that all CRCs occurring in patients under 50 be tested, and also all CRCs occurr…”
MethodMicrosatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundClues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundIonov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708 · cited 1×
“Molecular genetic studies of colorectal carcinoma (CRC) have found that 10% to 15% of CRCs have high-level microsatellite instability (MSI-H).(1,10,11,16,25,37) MSI most often occurs as a result of sporadic methylation of hMLH1, however, germline mutations in DNA mismatch repair genes also predispose to MSI-H CRCs in…”
BackgroundRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
International Histological Classification of Tumours
Weller, R. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.6.692-d · Cited by 2,042
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Research works printed but not linked: 1
- Krishna, 1996, Histopathologic features associated with microsatellite instability in colorectal carcinomas, (Abstract) Gastroenterology, 110, A546
Cited by
Items 201–285 of 285
Saller, J. J., Qin, D., Felder, S. I., & Coppola, D. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.02.003 · Cited by 4
Santos, A., Cristóbal, I., Rubio, J., Caramés, C., Luque, M., Sanz-Álvarez, M., Zazo, S., Madoz‐Gúrpide, J., Rojo, F., & García‐Foncillas, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012447 · Cited by 3
“According to the clinical guidelines, every regression grade was compared with the primary tumor [51].”
MethodGarcía, V. G. V., Ramírez, A. B., & Sacristán, H. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37673-0.50139-7 · Cited by 3
van Hees, J. E., Vlaming, M., Flach, R. N., Stathonikos, N., Suelmann, B. B. M., Meijer, R. P., Willemse, P.-P. M., & van Diest, P. J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105011 · Cited by 2
A continuously coupled attention neural network for MSI status classification in whole slide images
Pan, Z., Li, X., & Liu, L. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.109102 · Cited by 2
Cáncer de colon en Colombia, fenotipo molecular: tamizaje para síndromes con agregación familiar
Mabel Elena Bohórquez, L., Criollo, Á., Carvajal‐Carmona, L. G., & de Polanco, M. M. E. (2019) · Revista de la Asociación Colombiana de Ciencias Biológicas · doi:10.47499/revistaaccb.v1i31.185 · Cited by 2
Cesmecioglu, E., Yılmaz, Z. S., Yazıcı, H., Ersöz, Ş., & Munğan, S. (2024) · Cureus · doi:10.7759/cureus.57814 · Cited by 4
Takao, M., Yamaguchi, T., Eguchi, H., Suzuki, O., Mori, Y., Chika, N., Yamada, T., Okazaki, Y., Tomita, N., Nomizu, T., et al. (2024) · Surgery Today · doi:10.1007/s00595-024-02894-y · Cited by 2
“This model was constructed using the microsatellite instability (MSI) pathway used in predictive modeling for mismatch repair deficiency (MMRD)/MSI-high colorectal cancer (CRC) [17–20].”
Schmitz, L., Moretti, L., Marino, L., Giménez, L., & Bilbao, E. A. R. (2014) · Revista Española de Patología · doi:10.1016/j.patol.2013.10.002 · Cited by 2
Shiraj-Um-Mahmuda, S., Begum, F., Rahman, M. M., Islam, T., Shabnam, U. S., Afroz, S., Emita, U.-T.-N., & Islam, K. B. M. S. (2023) · Annals of Hematology & Oncology · doi:10.26420/annhematoloncol.2023.1426 · Cited by 2
Lymphocyte-rich Renal Cell Carcinoma
Petersson, F., Šíma, R., Sperga, M., Kazakov, D. V., Michal, M., Hora, M., Ferda, J., Šulc, M., Mičulka, P., Haferník, J., et al. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31821a931f · Cited by 2
Personalized immunotherapy in colorectal cancer
Ohtake, J., Wada, S., Yada, E., Fujimoto, Y., Uchiyama, H., Yoshida, S., Itoh, K., & Sasada, T. (2016) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2016.1174060 · Cited by 2
Carcinomas with Lymphoid Stroma within the Gastrointestinal Tract: Histology and Molecular Pathology
Max, N., Cathomas, G., & Langner, C. (2015) · Cited by 2
Immunohistochemistry of Cancers
Ghanadan, A., Jahanzad, I., & Abbasi, A. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_26 · Cited by 2
Les cancers colorectaux héréditaires vus par le pathologiste
Bibeau, F., Léger, A., Bazille, C., & Sèlves, J. (2020) · Annales de Pathologie · doi:10.1016/j.annpat.2020.02.017 · Cited by 4
Mosnier, J., Airaud, F., Métairie, S., Volteau, C., Bezieau, S., & Denis, M. G. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-207144 · Cited by 2
Zhang, Z., Wang, W., Song, Y., Liu, X., Yang, P., Shi, H., Tian, G., Yang, J., & Xing, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3874988/v1 · Cited by 2
Prospective validation of the microsatellite instability prediction models: RERtest6 and RERtest8
Roman, R. A., Rodón, N., Verdú, M., Calvo, M., García‐Peláez, B., Díaz, O., Biern, G., Serrano, T., & Puig, X. (2014) · Revista Española de Patología · doi:10.1016/j.patol.2014.08.001 · Cited by 1
Nair, G. G., Nair, V., & Abraham, U. M. (2022) · International Journal of Advanced Medical and Health Research · doi:10.4103/ijamr.ijamr_243_20 · Cited by 1
Wang, S., Chai, N., Xu, J., Yu, P., Huang, L., Wang, Q., Zhao, Z., Yang, B., Wei, J., Wang, X., et al. (2025) · JMIR Cancer · doi:10.2196/67379 · Cited by 1
Lee, J.-A., Park, H. E., Jin, H., Jin, L., Yoo, S.-Y., Cho, N., Bae, J. M., Kim, J. H., & Kang, G. H. (2024) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2024.09.26 · Cited by 1
“CIMP and MSI have been shown to be associated with enhanced tumor-infiltrating lymphocyte (TIL) density [17,18].”
SHAHID, M., Wang, D., Saller, J. J., Ryzhova, E., Qin, D., Magliocco, A. M., & Coppola, D. (2019) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20131 · Cited by 1
Cancer colorectal : compte rendu anatomopathologique type en 2014
Bibeau, F., & Goldman‐Lévy, G. (2014) · ONCOLOGIE · doi:10.1007/s10269-014-2462-3 · Cited by 1
“une réaction Crohn-like représentent des critères morphologiques suggérant une MSI [36,37].”
BackgroundLiu, Z.-Y., Jia, Q.-C., Wang, W. J., Liu, Y.-X., Wang, R., & Li, J.-Y. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/9012063 · Cited by 1
“Patients with MSI-H CRC generally have a better prognosis and a more effective immune response than patients with MSS CRC [4].”
BackgroundInfluentialLiu, P., Jiao, F., Zhang, Z., Zhao, F., Cai, J., Chen, S., Fu, T., & Li, M. (2022) · PubMed · Cited by 2
Patch-Based Coupled Attention Network to Predict MSI Status in Colon Cancer
Li, X., & Liu, L. (2024) · Lecture notes in computer science · doi:10.1007/978-981-97-5131-0_12 · Cited by 1
Owens, S. R., & Greenson, J. K. (2013) · Surgical pathology clinics · doi:10.1016/j.path.2013.05.005 · Cited by 1
Self-citationHereditary Gastrointestinal Cancers
Thirumurthi, S., Vilar, E., & Lynch, P. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-18890-0_33 · Cited by 1
(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00020-9 · Cited by 1
Komut, N., Bektaş, S., & Yıldırım, E. (2022) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2022.151933 · Cited by 1
Lower Gastrointestinal Tract and Microsatellite Instability
Li, J., & Lin, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8062-5_25 · Cited by 1
“References: [17, 70–73]”
Das Lynch-Syndrom: Klinische, pathologische und genetische Erkenntnisse
Schneider, R. A., Schneider, C., Kloor, M., Fürst, A., & Möslein, G. (2012) · coloproctology · doi:10.1007/s00053-012-0309-1
Somatic Alterations and Targeted Therapy
Cushman‐Vokoun, A. M. (2011) · Springer eBooks · doi:10.1007/978-1-61779-530-5_4
Discovery and application of colorectal cancer protein markers for disease stratification
Zhou, J. (2013) · The Sydney eScholarship Repository (The University of Sydney)
Cáncer de endometrio en el síndrome de Lynch
Bats, A., Bensaid, C., Huchon, C., Metzger, U., Frère‐Belda, M. L., Buecher, B., Laurent‐Puig, P., & Lecuru, F. R. (2012) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(12)61939-0 · Cited by 2
Les cancers héréditaires colorectaux vus par le pathologiste
Sèlves, J. (2010) · Annales de Pathologie · doi:10.1016/j.annpat.2010.08.006
Les cancers héréditaires vus par le pathologiste
Bibeau, F. (2010) · Annales de Pathologie · doi:10.1016/j.annpat.2010.08.003
Aspectos genético-moleculares asociados con el desarrollo del carcinoma colorrectal
Bohórquez, M., Estrada-Florez, A. P., Criollo, R. Á. A., Prieto, S. R., de Polanco, M. M. E., & Carvajal, C. L. G. (2015)
Medical Oncology Management of Hereditary Colorectal Cancer
Vilar, E., Salazar, R., & Tabernero, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-74259-5_25
HUBUNGAN EKSPRESI NEGATIF MLH-1 DENGAN GAMBARAN KLINIKOPATOLOGIK KARSINOMA KOLOREKTAL
Syukri, S. A., Tofrizal, T., Asri, A., & Agus, S. (2019) · Jurnal Kesehatan Andalas · doi:10.25077/jka.v8i1s.915
Tumors of the Gastrointestinal System Including the Pancreas
Taggart, M. W., Foo, W. C., & Lee, S. M. (2020) · Springer eBooks · doi:10.1007/978-3-319-96681-6_12
Investigating the Role of ARID1A Inactivation in Colon Cancer Pathogenesis
Mathur, R. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Histopathological Findings in Prophylactic Surgical Specimens
Dılek, F. H., & Kahraman, D. İ. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-66853-2_26
Genomic Applications in Colorectal and Pancreatic Tumors
Jung, A., & Hruban, R. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0727-4_25
Rüschoff, J., & Büttner, R. (2013) · Springer eBooks · doi:10.1007/978-3-642-02322-4_34
Immunohistochemistry of Cancers
Ghanadan, A., Jahanzad, I., & Abbasi, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_29
Chemoresistance and metastasis in colorectal cancer
Wong, S. Q. R. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/155418
Cáncer de endometrio en el síndrome de Lynch
Khider, H., Koual, M., Nguyen-Xuan, H.-T., Frère‐Belda, M. L., Perkins, G., Blons, H., Crespel, C., Nos, C., Laurent‐Puig, P., & Bats, A. (2020) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(20)44316-4
Rekhtman, N., Baine, M. K., & Bishop, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-97508-5_12
RELATIONSHIP OF DIRTY NECROSIS WITH HISTOPATHOLOGICAL GRADING IN COLORECTAL ADENOCARCINOMA
Listiyaningsih, Lubis, N. D., Delyuzar, & Mariedina, C. T. (2022) · International Journal of Research Publications · doi:10.47119/ijrp1001051720223657
Dsouza, L. L., Marla, N. J., & SHEKAR, J. C. (2021) · National Journal of Laboratory Medicine · doi:10.7860/njlm/2021/48273.2547
Tafti, S. M. A., Behboudi, B., Nili, F., & Hadizadeh, A. (2022) · Clinical Case Reports · doi:10.1002/ccr3.6336
Epithelial Neoplasms of the Colorectum
Patil, D. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-52794-1.00012-2 · Cited by 1
Shi, S., Gong, Y., Li, X., Ding, Y., Song, G., Liu, H., & Zhang, Z. (2023) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2022.0118
“histological characteristics compared to non-MSI-H CRCs (Greenson et al., 2009; Piredda et al., 2021) and that these patients show differences in survival rates and responses to various treatments (Andre et al., 2015; Le et al., 2015).”
Fujii, S., Kotani, D., Hattori, M., Nishihara, M., Shikanai, T., Hashimoto, J., Hama, Y., Nishino, T., Suzuki, M., Yoshidumi, A., et al. (2023) · doi:10.1158/1078-0432.c.6532572
Singh, H., Li, Y. Y., Spurr, L. F., Shinagare, A. B., Abhyankar, R., Reilly, E., Brais, L. K., Nag, A., Ducar, M. D., Thorner, A. R., et al. (2023) · doi:10.1158/1078-0432.c.6530721.v1
Fujii, S., Kotani, D., Hattori, M., Nishihara, M., Shikanai, T., Hashimoto, J., Hama, Y., Nishino, T., Suzuki, M., Yoshidumi, A., et al. (2023) · doi:10.1158/1078-0432.c.6532572.v1
Fujii, S., Kotani, D., Hattori, M., Nishihara, M., Shikanai, T., Hashimoto, J., Hama, Y., Nishino, T., Suzuki, M., Yoshidumi, A., et al. (2023) · doi:10.1158/1078-0432.22487718
Tunçtürk, B., Alabalık, U., & Keleş, A. N. (2024) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2024.2356864
“The absence of dirty necrosis was generally associated with dMMR CRCs [24].”
George, D. M., Lakshminarayanan, M., & Lakshmanan, A. (2024) · Apollo Medicine · doi:10.1177/09760016241303575 · Cited by 1
“[18,21] with specific primers.”
InfluentialCao, W., Hu, H., Guo, J., Qin, Q., 练延帮, Li, J., Wu, Q., Chen, J., Wang, X., & Deng, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22624492
Bodalal, Z., Hong, E. K., Trebeschi, S., Kurilova, I., Landolfi, F., Bogveradze, N., Castagnoli, F., Randon, G., Snaebjornsson, P., Pietrantonio, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26943249
Cao, W., Hu, H., Guo, J., Qin, Q., 练延帮, Li, J., Wu, Q., Chen, J., Wang, X., & Deng, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22624498
Cao, W., Hu, H., Guo, J., Qin, Q., 练延帮, Li, J., Wu, Q., Chen, J., Wang, X., & Deng, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22624501
Cao, W., Hu, H., Guo, J., Qin, Q., 练延帮, Li, J., Wu, Q., Chen, J., Wang, X., & Deng, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22624504
Cao, W., Hu, H., Guo, J., Qin, Q., 练延帮, Li, J., Wu, Q., Chen, J., Wang, X., & Deng, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22624495
Cao, W., Hu, H., Guo, J., Qin, Q., 练延帮, Li, J., Wu, Q., Chen, J., Wang, X., & Deng, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22624510
Damayanthi, T. (2026) · medRxiv · doi:10.64898/2026.03.03.26347325
Colorectal cancer computed tomography imaging features involving microsatellite instability
Stearns, J., McLaughlin, S., Kuckelman, T., Hutzley, S., Chiu, A., Kloft, L., Bay, C. R., Kundranda, M. N., & Chang, J. H.-C. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i3.114756
Guerrón-Gomez, G., Mendivelso-González, D., Chaves-Cabezas, V., Cháves, J. J., Riaño-Moreno, J. C., & Rafael, P.-M. (2026) · International Journal of Colorectal Disease · doi:10.1007/s00384-026-05146-2
“Additionally, MSI-H tumors are associated with a high neoantigen burden [7–9].”
Jikurashvili, M., Narimanishvili, G., Gotsadze, I., Mariamidze, A., Chechelashvili, D., Gendzekhadze, M., Matcharashvili, S., Datunashvili, G., & Tchokhuri, S. (2026) · Cureus · doi:10.7759/cureus.109954
Histological predictors of mismatch repair deficiency in endometrial endometrioid carcinoma
Caindec, A. M., Quddus, M. R., Singh, K., Islam, S., Manrai, P. A., Sung, C. J., Liang Cheng, C., & Marketkar, S. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156590
Chibaudel, B., Dainese, L., Carola, É., Goyer, P., Richa, H., Saget, A., Oberlin, O., Marijon, H., Perez‐Staub, N., de Gramont, A., et al. (2026) · Cancers · doi:10.3390/cancers18122006 · Cited by 1
“Fourth, subclonal or heterogeneous dMMR within the tumor may result in patchy staining patterns that mimic isolated loss but do not reflect a fully MSI-high molecular phenotype [26,27].”
Hussein, E. A. F., Bakeer, R. M., & Ahmed-Farid, O. A. (2026) · Egyptian Journal of Pathology · doi:10.4103/egjp.egjp_7_26
Li, J., Hughes, A. E. O., Wang, T., Byrnes, K., Duncavage, E. J., & Liu, X. (2026) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqag090
Kosgallana, E. W., Wijetunge, S., Malaviarachchi, S. L., Prathapan, S., Hegoda, S., Ratnatunga, K., Ratnayake, R. M. P., KANDEGEDARA, S., Gamage, B. D., Kumarasinghe, I. H. S., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-16615-w
“It also agrees with other predictive scores that have included a cut-off point of > 2/HPF, though they have counted in 5 HPF and taken the average per HPF [39, 45].”
InfluentialEsfahani, N. G., Emadi‐Baygi, M., Khanteymoori, A., Kakhaki, P. D., & Azar, B. (2026) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2026.101800 · Cited by 1
Atmış, Ö., Ocak, S., Pehlivan, F. S., Mavili, H. S., Tan, A., & Ayhan, S. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-05219-0
“This interpretation is consistent with previous studies showing that MSI/dMMR colorectal carcinomas can be enriched by pattern-based assessment of morphologic features such as mucinous differentiation, tumor-infiltrating lymphocytes, and Crohn-like lymphoid reaction [4, 9, 15, 19, 22, 23].”
Nguyen, N. H., Lý, K. N., & Le, N. Q. K. (2026) · Computers · doi:10.3390/computers15090626
Kanikella, E. R., Raparthi, S., & Masa, P. (2026) · World Journal of Current Medical and Pharmaceutical Research · doi:10.37022/wjcmpr.v8i3.454
Guo, L., Park, E., Higgins, P. J., Zhang, X., Zhou, J., Darwish, N. H. E., & Lee, H. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04594-0
Bibeau, F., Leaha, C., Benamar, A., Bouidioua, A., Chateau, M., Maran-Gonzalez, A., & Goldman‐Lévy, G. (2015) · Côlon & Rectum · doi:10.1007/s11725-015-0570-x
Metadata
- Authors
- Greenson, J. K., Huang, S.-C., Herron, C., Moreno, V., Bonner, J. D., Tomsho, L. P., Ben-Izhak, O., Cohen, H. I., Trougouboff, P., Bejhar, J., Sova, Y., Pinchev, M., Rennert, G., & Gruber, S. B.
- Affiliations
- Michigan Medicine (US)
- Institut Català d'Oncologia (ES)
- Western Galilee Hospital (IL)
- Emek Medical Center (IL)
- Bnai Zion Medical Center (IL)
- Corresponding author
- Greenson, Joel K.
- Sova, Yanina
- Venue
- American Journal of Surgical Pathology
- Published
- 2009-01
- Volume
- 33
- Issue
- 1
- Pages
- 126-133
- ISSN
- 0147-5185 (ISSN-L)
- PMC
- PMC3500028
- OpenAlex
- W2055732173
- Cited by
- 286
- References
- 43
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 20 · 2023: 30 · 2022: 31 · 2021: 22 · 2020: 20 · 2019: 16 · 2018: 8 · 2017: 11 · 2016: 7 · 2015: 15 · 2014: 11 · 2013: 18 · 2012: 19
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA081488)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, MSI-H colorectal cancer, Lynch syndrome, tumor-infiltrating lymphocytes, mucinous differentiation, tumor location, tumor differentiation, logistic regression prediction model
- MeSH terms
- Adenocarcinoma, Adult, Age Factors, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Regression Analysis, ROC Curve, Sensitivity and Specificity, Colorectal Neoplasms, Lymphocytes, Tumor-Infiltrating, Area Under Curve, Reverse Transcriptase Polymerase Chain Reaction, Microsatellite Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.